Use and Disclosure of Individual Client Public Information Clause Samples

Use and Disclosure of Individual Client Public Information. All Clients Arrest Records, Court, Probation, or any other information collected regarding the Clients Case (all public information), whether obtained from the Client, court clerk, or any other source, is confidential and must be maintained, stored and used in a responsible manner so as to ensure safety and confidentiality. Confidentiality of such information is a client privilege provided by COC and is not unconditional. In the following situations duty to inform overrides confidentiality privileges: (a) Any situation where the Client has publicly posted a communication in writing or in print among other things, an artificial and unprivileged publication, which tends to injure a party in its occupation, against the Agency or the Staff that warrants a response to protect the Agency or the Agency Staff from injury to reputation or business. (b) Any situation where the Client has initiated in writing or in print among other things, a chargeback with cardholder's issuing bank. When a client disputes an order, and files a chargeback that warrants a response from COC to protect the Agency or the Agency Staff from financial injury to business and reputation with card associations, COC has an opportunity to contest the chargeback dispute by participating in a series of predefined steps created by the card associations with the issuing and acquiring banks, who act as mediators between the customer and the merchant.
View Source
Use and Disclosure of Individual Client Public Information. All Clients Arrest Records, Court, Probation or any other information collected regarding the Clients Case (all public information), whether obtained from the Client, court clerk, or any other source, is confidential and must be maintained, stored and used in a responsible manner so as to ensure safety and confidentiality. Confidentiality of such information is a Client privilege provided by Court Ordered Classes and is not unconditional. In the following situations duty to inform overrides confidentiality privileges: (a) Any situation where the Client has publicly posted a communication in writing or in print among other things, an artificial and unprivileged publication, which has a tendency to injure a party in its occupation, against the Agency or the Staff that warrants a response to protect the Agency or the Agency Staff from injury to reputation or business. (b) Any situation where the Client has initiated in writing or in print among other things, a chargeback with cardholder's issuing bank. When a client disputes an order, and files a chargeback that warrants a response from Court Ordered Classes to protect the Agency or the Agency Staff from financial injury to business and reputation with card associations, Court Ordered Classes has an opportunity to contest the chargeback dispute by participating in a series of predefined steps created by the card associations with the issuing and acquiring banks, who act as mediators between the customer and the merchant.
View Source

Related to Use and Disclosure of Individual Client Public Information

  • Use and Disclosure of Confidential Information Notwithstanding anything to the contrary contained in this Agreement, and in addition to and not in lieu of other provisions in this Agreement:

  • Non-Disclosure of Non-Public Information (a) The Company shall not disclose non-public information to the Investor, advisors to or representatives of the Investor unless prior to disclosure of such information the Company identifies such information as being non-public information and provides the Investor, such advisors and representatives with the opportunity to accept or refuse to accept such non-public information for review. The Company may, as a condition to disclosing any non-public information hereunder, require the Investor's advisors and representatives to enter into a confidentiality agreement in form reasonably satisfactory to the Company and the Investor. (b) Nothing herein shall require the Company to disclose non-public information to the Investor or its advisors or representatives, and the Company represents that it does not disseminate non-public information to any investors who purchase stock in the Company in a public offering, to money managers or to securities analysts, provided, however, that notwithstanding anything herein to the contrary, the Company will, as hereinabove provided, immediately notify the advisors and representatives of the Investor and, if any, underwriters, of any event or the existence of any circumstance (without any obligation to disclose the specific event or circumstance) of which it becomes aware, constituting non-public information (whether or not requested of the Company specifically or generally during the course of due diligence by such persons or entities), which, if not disclosed in the prospectus included in the Registration Statement would cause such prospectus to include a material misstatement or to omit a material fact required to be stated therein in order to make the statements, therein, in light of the circumstances in which they were made, not misleading. Nothing contained in this Section 8.2 shall be construed to mean that such persons or entities other than the Investor (without the written consent of the Investor prior to disclosure of such information) may not obtain non-public information in the course of conducting due diligence in accordance with the terms of this Agreement and nothing herein shall prevent any such persons or entities from notifying the Company of their opinion that based on such due diligence by such persons or entities, that the Registration Statement contains an untrue statement of material fact or omits a material fact required to be stated in the Registration Statement or necessary to make the statements contained therein, in light of the circumstances in which they were made, not misleading.

  • Use and Disclosure of Protected Health Information The Business Associate must not use or further disclose protected health information other than as permitted or required by the Contract or as required by law. The Business Associate must not use or further disclose protected health information in a manner that would violate the requirements of HIPAA Regulations.

  • Non-Disclosure of Proprietary Information The Officer acknowledges that all Proprietary Information is received or developed by him in confidence and is the property of the Company. During the period of engagement and thereafter, the Officer will not, directly or indirectly, except as required by the normal business of the Company or expressly consented to in writing by the Company: (i) disclose, publish or make available, other than to an authorized employee, officer, or Officer of the Company, any Proprietary Information; (ii) sell, transfer or otherwise use or exploit any Proprietary Information; (iii) permit the sale, transfer, or use or exploitation of any Proprietary Information by any third party; or (iv) retain upon termination or expiration of the Period of Engagement any Proprietary Information, any copies thereof or any other tangible or retrievable materials containing or constituting Proprietary Information.

  • Disclosure of Confidential Information Any Finance Party may disclose: (a) to any of its Affiliates and Related Funds and any of its or their officers, directors, employees, professional advisers, auditors, partners and Representatives such Confidential Information as that Finance Party shall consider appropriate if any person to whom the Confidential Information is to be given pursuant to this paragraph (a) is informed in writing of its confidential nature and that some or all of such Confidential Information may be price-sensitive information except that there shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of the information or is otherwise bound by requirements of confidentiality in relation to the Confidential Information; (b) to any person: (i) to (or through) whom it assigns or transfers (or may potentially assign or transfer) all or any of its rights and/or obligations under one or more Finance Documents and to any of that person’s Affiliates, Related Funds, Representatives and professional advisers; (ii) with (or through) whom it enters into (or may potentially enter into), whether directly or indirectly, any sub-participation in relation to, or any other transaction under which payments are to be made or may be made by reference to, one or more Finance Documents and/or one or more Obligors and to any of that person’s Affiliates, Related Funds, Representatives and professional advisers; (iii) appointed by any Finance Party or by a person to whom paragraph (b)(i) or (ii) above applies to receive communications, notices, information or documents delivered pursuant to the Finance Documents on its behalf (including, without limitation, any person appointed under paragraph (c) of Clause 25.14 (Relationship with the Lenders)); (iv) who invests in or otherwise finances (or may potentially invest in or otherwise finance), directly or indirectly, any transaction referred to in paragraph (b)(i) or (b)(ii) above;